TG6050
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TG6050, covering 2025-07-09 to 2025-07-09. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Trial of TG6050 in Patients With Metastatic Non-Small Cell Lung Cancer (Delivir) [Phase 1]